跳至主要内容
临床试验/NCT04817982
NCT04817982已完成2 期

Does Perineural Dexamethasone Increase the Duration of an Ulnar Nerve Block When Controlling for Systemic Effects? A Randomised, Blinded, Placebo-controlled, Paired, Non-inferiority Trial in Healthy Volunteers.

Zealand University Hospital1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2021年4月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
16
试验地点
1
主要终点
Duration of the sensory nerve block, assessed by temperature discrimination (cold swab)

研究概览

简要总结

Investigators will assess if perineural dexamethasone can increase the duration of an ulnar nerve block when controlling for systemic effects in healthy volunteers.

详细描述

Healthy volunteers will have bilateral ulnar nerve blocks performed with bupivacaine on two different days with a minimum of 14 days wash-out. On one day, the participants will also receive dexamethasone in one arm and placebo in the other. On the other day, the participants will also receive placebo in one arm and lidocaine in the other. By this using this design, the investigators will be able to assess if perineural dexamethasone can increase the duration of an ulnar nerve block when controlling for the systemic effects. Furthermore, to ensure blinding, the investigators have also incorporated the lidocaine group which also allows for the assessment of the effects of adding lidocaine to a peripheral nerve block with bupivacaine. The order of which the participant will receive dexamethasone and lidocaine will be random. It will also be random in which arm the participant receives dexamethasone and lidocaine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The trial medication will be identical in appearance and will be prepared in syringes of identical appearance with an identical volume of trial medication by an un-masked nurse who is not otherwise involved in the trial. The participant, anaesthesiologist performing the blocks, the investigators, and the outcome assessors for all outcomes will be masked to treatment allocation.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of 18 years or above
  • Must fully understand the protocol and sign written informed consent
  • American Society of Anaesthesiologists Physical Status Classification System of 1 or 2
  • Body Mass Index above 18 kg/m^2
  • For fertile women, safe contraceptives for the last month and negative urine human chorionic gonadotropin is required

排除标准

  • Participants unable to cooperate
  • Participants unable to speak or read Danish
  • Age above 65 years
  • Cardiovascular disease
  • Allergy to study medication
  • History of alcohol or substance abuse
  • Intake of corticosteroids within the last 14 days
  • Daily intake of prescription analgesia within the last four weeks
  • Intake of over-the-counter analgesia within the last 48 hours
  • Neuromuscular diseases or wounds on the arms or hands preventing adequate test or block performance.
  • Diabetes mellitus

研究组 & 干预措施

Perineural dexamethasone

Experimental

Bilateral ulnar nerve blocks with bupivacaine. Dexamethasone will be added perineurally in this arm on the same day as the 'systemic dexamethasone' group.

干预措施: Perineural dexamethasone (Drug)

Systemic dexamethasone

Active Comparator

Bilateral ulnar nerve blocks with bupivacaine. Placebo (saline) will be added perineurally in this arm on the same day as the 'perineural dexamethasone' group. Thereby, this ulnar nerve block will only be affected by the perineurally added dexamethasone that is absorbed and redistributed systemically.

干预措施: Systemic dexamethasone (Drug)

Placebo

Placebo Comparator

Bilateral ulnar nerve blocks with bupivacaine. Placebo (saline) will be added perineurally in this arm on the same day as lidocaine group. This will be the actual placebo group.

干预措施: Placebo (Drug)

Perineural lidocaine

Active Comparator

Bilateral ulnar nerve blocks with bupivacaine. Lidocaine will be added perineurally in this arm on the same day as the actual placebo group.

干预措施: Lidocaine (Drug)

结局指标

主要结局

Duration of the sensory nerve block, assessed by temperature discrimination (cold swab)

时间窗: 24 hours

The investigators will stimulate the skin with an alcohol swab and ask the participant if it is cold or warm. The duration of the sensory block will be defined as the time to the alcohol swab feels cold again. The investigators will assess temperature discrimination every 30 minutes.

次要结局

  • Duration of the sensory nerve block, assessed by mechanical discrimination (pinprick)(24 hours)
  • Duration of analgesia, assessed by pain during tonic heat stimulation (heated thermode)(24 hours)
  • Duration of the motor block, assessed by fifth finger abduction(24 hours)
  • Onset of the sensory nerve block, assessed by temperature discrimination (cold swab)(24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Unknown
2 期
Perineural Dexmedetomidine for Ulnar Nerve Block.Healthy
NCT03222323Zealand University Hospital22
已完成
4 期
Perineural Steroids for Peripheral Nerve BlocksOsteoarthritis, Knee
NCT02462148Wake Forest University Health Sciences85
终止
不适用
Dexamethasone and Block Duration in Upper ExtremityDuration of Pain Relief
NCT01756573University of Chicago5
已完成
3 期
Perineural Dexamethasone in Femural Nerve Block After Ligament ReconstructionPostoperative Pain
NCT02749162Foisor Orthopedics Clinical Hospital90
进行中(未招募)
1 期
Does dexamethasone increase the duration of a peripheral nerve block when applied directly to the nerve?We will not assess a specific medical condition or disease as only healthy volunteers are included. We will assess if perineural dexamethasone increases the duration of a peripheral nerve block (i.e. as used in orthopaedic surgery) when controlling for systemic effects.MedDRA version: 20.0Level: LLTClassification code 10002322Term: Anesthesia application siteSystem Organ Class: 100000004867MedDRA version: 20.0Level: LLTClassification code 10002324Term: Anesthesia injection siteSystem Organ Class: 100000004867MedDRA version: 21.0Level: LLTClassification code 10002325Term: Anesthesia localSystem Organ Class: 100000004865MedDRA version: 21.0Level: LLTClassification code 10021946Term: Infiltration anesthesiaSystem Organ Class: 100000004865MedDRA version: 20.1Level: LLTClassification code 10022047Term: Injection site anesthesiaSystem Organ Class: 100000004867MedDRA version: 21.1Level: LLTClassification code 10002321Term: AnesthesiaSystem Organ Class: 100000004852MedDRA version: 20.0Level: LLTClassification code 10038286Term: Regional nerve blockSystem Organ Class: 100000004865
EUCTR2020-004242-10-DKCentre for Anaesthesiological Research, Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark16